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Abstract 
Background: Tuberculosis (TB) remains one of the globe’s deadliest communicable diseases. 
The homeless individuals are at high risk to acquire TB and multi-drug resistant TB (MDR-TB), 
because of their poor living conditions and risky behaviors. Tuberculosis and MDR-TB in the 
homeless individuals can pose a risk to entire communities. However, the magnitude of the 
problem in Ethiopia is not yet determined.  
Objectives: The aim of this study was to determine the prevalence and associated factors of 
smear positive pulmonary TB (PTB) and MDR-TB among homeless individuals in Dessie and 
Debre Birhan towns, Northeast Ethiopia.  
Materials and Methods: A community based cross-sectional study design was conducted from 
February to April 2015. Using an active screening with cough of ≥ 2 weeks, 351 TB suspects 
homeless individuals were participated in this study. Data were collected by using pre-tested and 
structured questionnaire. Spot-morning-spot sputum sample were collected and examined for 
acid-fast bacilli (AFB) using florescence microscopy by Auramine O staining technique. All 
AFB positive sputum was further analyzed by GeneXpert for detection of Mycobacterium 
tuberculosis complex and rifampicin resistant gene. Bivariate and multivariate logistic 
regressions were applied to identify factors associated with smear positive PTB and P-value 
<0.05 were considered as statistically significant. 
Results:  The prevalence of smear positive PTB and MDR-TB were 2.6% [95% CI: 1.3 – 5] and 
0% respectively among TB suspect homeless individuals. Extrapolation of this study finding 
implies that there were 505 smear positive PTB per 100,000 homeless individuals. Smoking 
cigarette regularly for greater than 5 years [AOR =10.08, 95% CI: 1.04, 97.66], body mass index 
lower than 18.5 [AOR = 6.94, 95% CI: 1.17, 41.07] and HIV infection [AOR = 6.75, 95% CI: 
1.14, 40.07] were significantly associated with smear positive PTB.  
Conclusion: This study indicates high prevalence of smear positive PTB, but MDR-TB was not 
found among TB suspect homeless individuals. The estimated point prevalence of smear positive 
PTB in homeless individuals was about 4.67 times higher than the general population. Smoking 
cigarette regularly for greater than 5 years, malnutrition and HIV infection were factors 
associated with smear positive PTB. Conducting active surveillance of TB and developing and 
implementing specific TB prevention and control strategies are highly recommended. Further 
research is needed to strengthen and explore the problem among homeless individuals in depth 
with large sample sizes and advanced diagnostic techniques.  
Keywords: Homeless individuals, Tuberculosis, Risk factors, Northeast Ethiopia 
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1. Introduction 
1.1. Background 
Tuberculosis (TB) is an airborne chronic infectious disease mainly caused by Mycobacterium 
tuberculosis (MTB). Occasionally the disease can also be caused by M. bovis and M. africanum 
(1). The tubercle bacilli are a rod-shaped called “acid-fast bacilli (AFB)” due to their lipid-rich 
cell wall ability to retain the primary stain even after decolorizing with acid-alcohol. In addition, 
the bacilli are  non-motile, non-spore forming and slow-growing with a generation time of 12 to 
18 hours(2). The bacilli are  also obligate aerobes, grow most successfully in areas of the body 
with  lots of blood and oxygen due to this it most commonly affects the lungs, pulmonary TB 
(PTB), but may also affect any organ or tissue outside of the lungs, extra pulmonary TB 
(EPTB)(3).  
Tuberculosis is mostly transmitted by inhalation of infected droplet nuclei, which are discharged 
in the air when a person with untreated PTB coughs, sneezes, spits and sings(4). A single cough 
can generate about 3,000 droplet nuclei and in areas with poor ventilation, the bacilli could 
remain suspended in the air for several hours.  If inhaled, a droplet nucleus is small enough in size 
(5 to 10 micron) to reach an alveolus in the lung. Once the bacilli reach the alveolar region, 
alveolar macrophages engulf and control multiplication of bacilli in 90% - 95% of the exposed 
individuals and no apparent disease is noted i.e. latent infection stage. Only about 5-10% of such 
infected persons (primary infection) develop active disease in their lifetime without underlying 
health problems. The most common symptom of PTB is a productive cough for 2 weeks and more 
duration, which may be accompanied by other symptoms (shortness of breath, chest pains, 
hemoptysis, loss of appetite, weight loss, fever, night sweats and fatigue)(5).  
Globally PTB accounts for 85 % of all TB cases; among them smear positive PTB comprises 75% 
to 80%. Smear positive PTB are the most infectious and most likely to transmit their disease in to 
the surroundings; thus, they are the focus for infection control. Therefore, the identification of TB 
suspects (cough for 2 weeks and more duration) and screening them by examination of sputum 
allows discovering those who are transmitting the disease(6). The most common method used for 
diagnosing PTB in adult is sputum smear microscopy, in which the bacilli are observed in sputum 
samples examined under a microscope. However, culturing mycobacteria is the gold standard 
method but not feasible as smear microscopy. Following recent breakthroughs in TB diagnostics, 
the use of rapid molecular tests, like genexpert to diagnose TB and drug-resistant  TB(DR- TB ) is 
increasing(7). Since TB is a curable disease, treatment is often success and involves a 
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combination of anti-TB drugs. However, if untreated it leads to deaths within 5 years in at least 
half of the patients and about 25 to 30% could remain chronically ill, as a result continuing to 
spread the disease in the community(5).  
 Multi-drug resistant TB (MDR-TB) is MTB resistant to at least isoniazid (INH) and rifampicin 
(RIF), the two most common powerful first-lines anti-TB drugs(8). The emergence of DR strains 
is a natural phenomenon, exclusively associated with random chromosomal mutations of 
MTB(9). It is largely being the consequence of human error as a result of poor patient 
management. With an appropriate and timely treatment with second line anti-TB drugs, MDR-TB 
is also curable(10). 
Poverty, malnutrition, over-crowded or unsanitary living conditions, low socioeconomic status, 
drug abuse, cigarette smoking, alcoholism, close contact with active TB cases, human 
immunodeficiency virus /acquired immune deficiency syndrome(HIV/AIDS) and  increasing 
numbers of homeless people are the greatest risk factors for the acquisition of active TB(3). The 
synergy between TB and HIV is strong, being infected with HIV increases susceptibility to 
infection with MTB, the risk of progression to active TB disease. It also increases the chance of 
re-infections and relapses of TB. The life time risk of HIV infected individuals to develop TB is 
20-37 times  higher  than HIV uninfected individuals(6). In the developing world TB rates are 
highest among young adults, this leads to grave socio-economic consequences in a country(7). 
1.2. Statement of the problem 
Tuberculosis remains one of the globe’s deadliest communicable diseases. About one third of the 
world’s population is estimated to be infected with tubercle bacilli and hence at risk of developing 
active disease. Currently TB ranks as the second leading cause of death from an infectious disease 
worldwide, next to HIV/ADIS. According to World Health Organization (WHO) global TB report 
2014, globally an estimated 9.0 million people developed TB, of whom 1.1 million (13%) were 
HIV positive in the year 2013. In addition 1.5 million died from the disease, of these 360,000 
were HIV positive(11). The number of TB deaths is unacceptably large given that most are 
preventable if people can access for diagnosis and the right treatment of the disease. Short-course 
regimens of first line anti- TB drugs that can cure about 90% of cases have been available for 
decades(1).  
Nowadays the emergence of MDR-TB has become a series threat to public health and an obstacle 
to effective TB control worldwide(7). There were an estimated 480,000 new cases of MDR-TB 
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and 210,000 deaths from MDR-TB worldwide. The African region had about one quarter of the 
globe’s TB cases (280/100,000 incident cases, more than double the global average of 
126/100,000) and the highest rates of mortality. The region also had an estimated 44,000 MDR-
TB cases among notified PTB cases in the year 2013. The proportion of TB cases co - infected 
with HIV is highest; overall, the region accounted for 78% of TB cases among people living with 
HIV(11). Tuberculosis and MDR-TB are  the leading causes of morbidity and mortality in the 
horn of Africa (12).  
Ethiopia is among the 22 high TB burden countries and among the 27 high MDR-TB burden 
countries in the world. Compounded with HIV/AIDS, TB has been a formidable risk to the 
country(5). According to WHO global TB report 2014, Ethiopia had an estimated 211 prevalent 
TB case per 100,000 populations and a total of 30,000 TB related deaths. There were 20,000 HIV-
positive incident TB cases. Among patients with notified PTB cases in the year 2013, an 
estimated 1,400 MDR-TB cases were found in  the country(11).  
Mycobacterium tuberculosis can infect anyone who lives and breathes in proximity to active cases 
but predominantly affects the poor, homeless and other socially marginalized groups who live in 
overcrowded conditions and/or lack access to healthcare(13). Globally 95% of new TB  cases and 
98% of deaths from TB are  occurred in the developing countries(14). 
Homelessness is a global problem; an estimated one hundred million to one billion people are 
homeless worldwide(15). Homelessness is becoming a common feature of cities and fast growing 
towns of the poor countries in Africa mainly  due to a very high increasing rate of rural-urban 
migration and poverty(16). Ethiopian cities also have a realm of homeless people, where they 
thrive in rough streets, bus stations, around the church, abandoned buildings,  market streets, and 
live in temporary shelter with relative inadequate facilities(17). 
Because of  poor living conditions and as they indulge in risky behaviors and lifestyle homeless 
people are exposed to many communicable disease(18). The death rate among this group of 
people is about 4 times higher than the general population(19). Homeless people are included in 
the high-risk classification for developing TB disease by Centers for Disease Control and 
prevention (CDC) as they suffer disproportionately from a variety of health problems and 
emergency shelters remain volatile TB transmission sites(20). 
Several risk factors including over-crowded environments, poverty, malnutrition, low socio-
economic status,  close contact with TB patients,  alcoholism, tobacco smoking, lack of stable 
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housing and  HIV /AIDS combine to make TB more prevalent in the homeless individuals. In 
addition being homelessness are creating favorable conditions for development and transmission 
of MDR-TB because these groups are hard-to-reach groups, poor diagnostic and treatment 
services, more likely to incomplete and inadequate TB treatment and poor management of the 
disease including infection control(21, 22). Many homeless TB patients often will not regard their 
health as a high priority and may prioritize substance needs such as food, shelter and providing 
for any addiction(23). Tuberculosis in homeless individuals is especially problematic because it 
may be highly contagious and can presents as advanced disease with poor outcomes, including 
mortality(24).  
These vulnerable populations in crowded congregate settings have  potential for  explosive 
transmission of TB and also resulted TB outbreaks(14). Even  in low TB incidence countries such 
as Canada, TB disease remains concentrated in homeless with outbreaks and continue to 
challenge TB control programs(25). Generally 72% of domestic TB outbreaks investigated by 
CDC in  the year 2002–2010 involved homelessness in developed countries(26). Therefore, 
appropriate health interventions should be done for homeless individuals to reduce the adverse 
outcomes of these communicable diseases(27). Currently, Ethiopia is working towards 
interrupting transmission of TB, and preventing emergence and spread of MDR-TB in the general 
population. In spite of these efforts, the problem remained a continuous challenge in the country 
(28). 
Although, homelessness is one of the greatest risk factors for the acquisition of TB, and 
homelessness is a problem in Ethiopian cities, as to my knowledge the prevalence and associated 
factors of smear positive PTB and MDR-TB among homeless individuals in Ethiopia has not been 
reported. Therefore the aim of this study was to determine the prevalence and associated factors 
of smear positive PTB and MDR-TB among homeless individuals in Dessie and Debre Birhan 
towns, Northeast Ethiopia. 
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2. Literature review 
2.1. Tuberculosis in homeless individuals 
For the homeless individuals, TB has been a serious health threat since the early 20th century(22).  
Homelessness is associated with a variety of  under-privileged  social conditions, behavioral and 
environmental risks that expose people to TB(18). Because of these homelessness-related TB 
remains a widespread problem(29). Prevention and control of TB and MDR-TB among these 
vulnerable groups can be hampered by delayed diagnosis, and poor treatment adherence and loss 
to follow up(30). Although homeless population should be the strategic group in which untreated 
TB diagnosed, little is known especially in developing country.    
2.2. Prevalence of tuberculosis in homeless individuals 
In many developed countries disproportionately high prevalence of active TB was reported 
among the homeless individuals, about 20 times higher than the general population(31). In Africa, 
where HIV/AIDS, poverty and chronic malnutrition are unacceptably rampant, the homeless 
individuals probably have a high burden of TB. However, published information about TB in 
African homeless individuals is very scarcy. 
A cross-sectional analysis conducted in United State of America (USA) showed that of 185,870 
TB cases reported from the 50 States and the District of Columbia from 1994 through 2003, 
11,369 (6.1%) were either culture confirmed or smear positive TB among homeless individuals. 
The annual proportion of TB cases associated with homelessness was (6.1%-6.7%)(32). Another 
retrospective study conducted in the same country from 2004 to 2009 showed that the prevalence 
of TB was 3.28 % among the homeless individuals. Tuberculosis was reported to be considerably 
greater among the homeless population compared to the state average(33). 
A retrospective study conducted in USA from 1994 to 2010 showed that of 270,948 reported TB 
cases, 16, 527 (6%) were  found in  homeless individuals. The TB incidence rate among homeless 
individuals ranged from 36 to 47 cases per 100, 000 populations in the year 2006 to 2010. 
Compared to the general population, homeless individuals had an approximately 10-fold increase 
in TB incidence(34). Tuberculosis is more prevalent respiratory infection among homeless 
individuals, the estimated annual PTB rate for Canada and the USA is 2/100,000 but the homeless 
individuals comprise a disproportionate burden of TB (1.6% to 6.8%)(35). 
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 Tuberculosis outbreak associated with a homeless shelter in Kane County, Illinois, between  
2007 and 2011 showed that despite the overall decline in TB incidence in the USA, a total of 28 
outbreak of TB occurred among homeless individuals(36). A prevalence survey of respiratory 
diseases conducted in Marseilles, in 2005 showed that among 221 homeless individuals, active 
PTB was found in 2 (1%) of individuals(37).  
A prospective study conducted in Medellin city, Colombia between July 2006 and December 
2007 among homeless individuals showed that the prevalence of TB was 7.9%. In this case, 426 
homeless individuals enrolled in the study and 34 were diagnosed as culture positive for 
MTB(38). A systematic review and meta-analysis of TB, hepatitis C virus, and HIV prevalence in 
homeless individuals showed that, of these infectious diseases the prevalence of TB  ranged from 
0·2% to 7·7%(19). 
A cross-sectional study conducted in Japan at the Osaka socio-medical center hospital between 
July 2007 and March 2008 showed that the prevalence of active TB was 1.5% among homeless 
individuals. According to annual TB patients’ registry database, the prevalence of active TB 
among residents in the Airin district was 0.65% in 2007, and the homeless individuals accounted 
for 79.3% of TB patients in that district. These estimates of active TB prevalence  in homeless 
individuals were noticeably higher than those of the total Japanese population and the Osaka city 
population in 2007(29).  
A cross-sectional study conducted in Seoul, South Korea between October 2009 and April 2010 
showed that the prevalence of active PTB diagnosed by chest radiography were 24.86%. This 
showed that the prevalence of active TB among homeless participants was much higher than the 
general population(24). Another cross-sectional study conducted in Rome from November 2006 
to November 2007 showed that prevalence of active TB among homeless  individuals was 
3.86%(39). 
 An intervention study conducted in North-eastern Poland between September and January 
2011 showed that among 121 homeless individuals, the prevalence of PTB was 4.13%. In this 
study participants were first screened by chest radiography, then sputum samples were 
examined by molecular testing and culture(40). A cohort study conducted in London on July 
2003 with 1941 eligible patients showed that an extremely high prevalence of TB was seen in 
homeless individuals (780/100,000) than the overall prevalence of TB (27/100,000). 
Homelessness was significantly associated with infectious TB, comprise 17% of TB cases among 
eligible patients(41). A study on vulnerability of homeless people to HIV, TB and Viral Hepatitis 
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in Tehran, Iran, between June and August 2012 with a convenience sample of 593 homeless 
individuals showed that the prevalence of active PTB was 1.2% and HIV infection were 
(3.4%)(27).  
The first Ethiopian National population based TB prevalence survey conducted between October 
2010 and June 2011 showed that, a total of 46,548 participants were first screened by chest 
radiography and TB suggestive symptoms. Among them a total of 6,080 (13%) TB suspect 
participants sputum was examined and smear positive PTB were found in 47(0.77%) participants. 
The point prevalence of smear positive PTB among people aged 15 and above was 108/100,000 
population(42). 
2.3. Prevalence of multi-drug resistant tuberculosis in homeless individuals 
A cross-sectional study conducted in USA between 1994 and 2003 showed that drug 
susceptibility test (DST) was performed for 661 TB patients homeless individuals among them, 
MDR-TB was found in 18 (2.7%) homeless individuals(32). Another retrospective study 
conducted in the same country between 1994 and 2010 showed that for 2101 homeless TB 
patients genotype test was performed among them, MDR-TB was found in 24(1.1%) homeless 
individuals(34). 
A cross-sectional analysis conducted in Busan Medical Center, Korea between January 2001 and 
December 2010 showed that DST was performed for 96 smear positive PTB homeless patients.  
The result indicated that 24 (25%) cases were resistant to one or more anti-TB drugs and 11 
(11.5%) cases were  MDR-TB(21). A cohort study conducted in London on  July 2003 showed 
that of 77 culture confirmed TB cases, 30 (39%) cases were resistance to one or more anti-TB 
drugs and 5 (6.5%) cases were MDR-TB  among homeless individuals(41).  
2.4. Factor associated with tuberculosis in homeless individuals 
 A cross-sectional study conducted in USA between 1994 and 2003 revealed that alcohol abuse, 
HIV infections and drug use were factors associated with TB among homeless individuals(32). 
Another retrospective study conducted in the same country between 2004 and 2009 showed that 
drug use, HIV/AIDS and environments such as congested living arrangements inside homeless 
place them at greater risk for contracting TB(33). A retrospective cohort study conducted in 
Montreal, Canada from 1996 to 2007 showed that HIV infection, smoking, alcohol and drug use 
were  factors associated with TB among homeless people(43). 
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 A cross-sectional study conducted in Seoul, South Korea showed  that risk factors for active PTB 
were a history of previous TB  and BMI less than 18.5(24). Similar  study conducted in Rome 
from November 2006 to November 2007 shows that under nutrition, smoking  and alcohol misuse 
are risk factors for  active TB development and all these conditions are associated with 
homelessness(39). 
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3. Justification of the study  
Tuberculosis and MDR-TB among homeless individuals is a public health concern. The homeless 
individuals are more vulnerable than the general population to acquire TB and MDR-TB, as they 
indulge in risky behaviors and lifestyle. Prevention and control of TB among these risk groups is 
hindered by delayed diagnosis, onward transmission and poor treatment adherence leading to the 
development of MDR-TB. These populations also have worse treatment outcomes including 
mortality. So these groups require vigorous scrutiny and innovative treatment strategies. As TB 
prevalence is one indicator of millennium development goals, this study will be significant, 
especially in countries where the incidence and prevalence of TB is high. 
In Ethiopia, even if there are a number of studies conducted on prevalence and associated factors 
of smear positive PTB and MDR-TB in different segment of population, the magnitude of the 
problem among homeless individuals is not yet determined. Better understanding of the 
characteristics of homeless individuals with smear positive TB and MDR-TB is critical for 
creating strategies to decrease disease incidence and for reducing associated factor in this 
vulnerable population. Thus, this community based cross-sectional study was conducted, to 
determine the prevalence and associated risk factors of smear positive PTB and MDR-TB among 
homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia. This study may 
serve as a baseline for future studies in our country particularly in this target population. 
Therefore, based on the findings of this study, recommendations might be provided to facilitate 
decision making to reduce potential sources of transmission and provide appropriate prevention 
and control measures for these high risk populations. Moreover, the result will have potentials for 
developing and implementing TB and MDR-TB prevention and control strategies in homeless 
individuals in the study area. Furthermore, as a disease is transmitted by aerosol it will persuade 
policy makers, program managers, health providers, community groups, nongovernmental 
organization and scientific communities to take action and conduct intervention for the well being 
of homeless people and general population at large. 
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4. Objectives  
4.1. General objective 
 To assess the prevalence and associated factors of smear positive pulmonary tuberculosis and 
multi-drug resistance tuberculosis among homeless individuals in Dessie and Debre Birhan 
towns, Northeast Ethiopia.  
4.2. Specific objectives 
 To determine the prevalence of smear positive pulmonary tuberculosis among homeless 
individuals. 
 To determine the prevalence of multi-drug resistance tuberculosis among homeless 
individuals. 
 To identify factors associated with smear positive pulmonary tuberculosis among homeless 
individuals. 
 . 
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5. Materials and Methods 
5.1.  Study area  
Dessie town is located in the Northeast part of Ethiopia in the South Wollo administrative zone of 
the Amhara Region, which is 400 km away from Addis Ababa, the capital city of Ethiopia. The 
town has a total area of 15.08 km
2 
with 10 kifleketema and a total population of 279,423. The 
climate is highland with an elevation of 2,470 meters. The city administration estimates the 
number of homeless individuals to be 2100 in the year 2014. 
Debre Birhan town is located in the Northeast part of Ethiopia in the North Shewa zone of the 
Amhara Region, about 120 kilometers Northeast of Addis Ababa on the paved highway to Dessie. 
The town has a total area of 14.71 km
2 
and a total population of 110,408. The climate is also 
highland with an elevation of 2,840 meters. The city administration estimates the number of 
homeless individuals to be 1900 in the year 2014. 
5.2.  Study design and periods 
A community based  cross-sectional study design was conducted from February 10 to April 30, 
2015 to assess the prevalence and associated factors of smear positive PTB and MDR-TB among 
homeless individuals in Dessie and  Debre Birhan towns, Northeast Ethiopia. 
5.3. Population 
5.3.1. Source population 
All homeless individuals who live in Dessie and Debre Birhan towns were source population for 
this particular study. 
5.3.2.  Study population  
Homeless individuals, who were aged >15 years and eligible during the study period were the 
study population.  
5.4.  Inclusion criteria 
Homeless individuals who had cough of two weeks and more duration were included in the study. 
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5.5. Exclusion criteria 
Homeless individuals who were unable to produce sputum and/or provided incomplete 
information were excluded from the study.  
5.6. Variables  
5.6.1. Dependent variable  
Smear positive pulmonary tuberculosis  
Multi- drug resistance tuberculosis 
5.6.2. Independent variable  
Socio demographic factors: - age, sex, marital status, religion, educational status 
Behavioral factors: - smoking, duration of smoking, alcohol drinking, duration of alcohol 
drinking, khat chewing, duration of khat chewing, drug using, duration of drug using 
Environmental factors:- duration of being homelessness, number of homeless individuals 
slept/live together in one restricted place, close contact with known TB patients, close contact 
with chronically cougher patients 
Morbidity history and status: - current TB suggestive symptoms, past TB history, past TB 
treatment starting, completion of TB treatment, BMI, HIV infection   
5.7. Operational definition  
Homeless individuals:- people who lack fixed, regular, and adequate night-time residence or who 
are street dwellers and living in emergency and temporary accommodation such as night shelters 
for more than one month(29).  
AFB smear positive – any positive with FM smear microscopy(44). 
5.8. Sample size determination and sampling technique 
5.8.1. Sample size  
The sample size was determined using a single population proportion formula with the 
assumption of 5% margin of error, 95% CI and 50% proportion 
 
                    n = z
2
α/2 p (1-p)/ d
2 
 
13 
 
Where, n =  the minimum sample size required 
             Zα/2 = critical value for normal distribution at the 95% CI, which is 1.96 
             d= relative precision 
             P = the prevalence of smear positive TB and MDR-TB among homeless individuals was 
taken as 0.5 since no previous similar study conducted in Ethiopia  
Substituting from the formula:  
n = (1.96)
2 
* 0.5(1-0.5) = 384 
                     
(0.05)
2 
Hence, the total population is less than 10,000: sample size correction formula was used 
 nf = no / (1+ (no/N)) 
Where, nf = final sample size 
             no = initial sample size 
             N = total population 
Substituting from the formula: 
nf = 384/(1+(384/4000)) 
nf = 350 
The final sample size will be 385 after taking into account a 10% non-response rate.
   
5.8.2. Sampling technique  
Using an active screening strategies to identify PTB suspects about 1,780 homeless individuals 
were screened during the study period for symptoms considered suggestive for TB, cough of two 
weeks or more duration according to the National TB manual(5). Out of the total screened, 385 
homeless individuals were had cough of > 2 weeks duration, were included in to the study.  
5.9. Data collection and laboratory methods  
5.9.1. Data collection  
A structured and pre-tested questionnaire was completed by 4 trained data collectors (2 laboratory 
technologists and 2 nurses) by face-to-face interview.  The questionnaire had four parts; socio 
demographic characteristics, behavioral characteristics, environmental factors and morbidity 
history and status of the study participants. A questionnaire was first developed in English and 
then translated in to Amharic language for appropriateness and clarity so; the participants were 
interviewed with their mother languages and finally retranslated to English by another language 
expert to check its consistency.  
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5.9.2.  Sputum sample collection and florescence microscopy examination 
A bout 3 to 10 ml of spot- morning-spot sputum samples were collected using coded and new, 
translucent, screw-capped specimen collection containers by laboratory technologist from the 
study participants. The sputum samples were placed in cold boxes immediately upon receipt and 
delivered to Dessie and Debre Birhan referral hospitals laboratory on the day of collection. 
Sputum-smear microscopy was performed using Primo Star iLED, light emitting diode (LED)- 
florescence microscopy (FM) by using Auramine O staining procedure as follows; a smear was 
prepared and dried, then heat-fixed. Stained the smear with filtered 0.1% Auramine O solution 
and kept the staining reagent for 20 minutes and washed well. Decolorized with 0.5% acid-
alcohol and kept for 3 minutes and gently rinsed with water. Counterstained with 0.5% potassium 
permanganate solution for 1 minute then gently rinsed with water and drained.  Finally, wept the 
back of the slide cleaned, air-dried and the stained slides were observed under 20x, 40x 
magnifications of FM for AFB. The AFB was appeared bright yellow against dark back ground 
materials(45).  
5.9.3. GeneXpert examination 
All AFB positive sputum samples were subjected to Cepheid GeneXpert MTB/RIF system in 
Dissie and Debre Birhan referral hospitals laboratory. The system is a fully automated nested real-
time polymerase chain reaction (PCR), which simultaneously detects Mycobacterium tuberculosis 
complex (MTBC) and mutations in the ribonucleic acid polymerase Beta subunit gene (rpoB), 
which are responsible for the resistance to RIF(46).  
To perform the test first, the GeneXpert assay sample reagent was added in a 2:1 ratio to the 
sample tubes to kill mycobacteria and liquefy the sputum sample. Then the mixture were 
vigorously shaken and allowed to sit for 10 minute and again shaken and allowed to sit for 
another 5 minute. Finally, 2 ml were pipetted into the GeneXpert cartridge and inserted into the 
GeneXpert instrument for PCR testing. By starting the test on the system software, the GeneXpert 
automates all the subsequent steps, including sample work-up, nucleic acid amplification, 
detection of the target sequence and result interpretation.  
The primers in the GeneXpert assay amplify a portion of the rpoB gene containing the 81 base 
pair “core” region. The probes are able to differentiate between the conserved wild-type sequence 
and mutations in the core region that are associated with resistance to RIF. The MTB/RIF assay 
as an entirely self-contained test with quality control incorporated. The assay includes a sample 
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processing control to control adequate processing of the target bacteria and to monitor the 
presence of inhibitors. In addition, a probe check control to validate reagent rehydration, PCR 
tube filling in the cartridge, probe integrity and dye stability(47). The detection of resistance to 
RIF  can be used as a surrogate marker for MDR-TB with a high level of accuracy, since 
resistance to RIF in most instances (greater than 90%) co-exists with resistance to INH(48).  
5.9.4. Rapid   HIV test  
To determine the HIV status of the study participants, pre-test counseling was provided by trained 
nurse. Then whole blood was collected by finger stick. The presence of HIV-1 and HIV-2 
antibodies was determined by using rapid test kit, HIV (1 + 2) antibody Colloidal Gold (KHB, 
Shanghai Kehua Bio-engineering Co Ltd, China) as a screening test, followed by HIV 1/2 STAT-
PAK® (Chembio Diagnostics, USA), when KHB result was reactive. Where the result of STAT-
PAK® was discordant with KHB, a third test, Unigold™ HIV (Trinity Biotech, Ireland), was also 
used as a tiebreaker to determine the test result following the manufacturers’ instruction. After 
testing, post test counseling was provided for all participants.   
5.9.5. Nutritional assessment 
The participants body weight and height was measured by digital scale to the nearest 0.1 kg and 
0.1 cm respectively. Body mass index is defined as the weight in kilogram of the individual 
divided by the square of the height in meter. It is used to determine the nutritional status of study 
participants into malnutrition (BMI = less than 18.5 kg/m2), normal (BMI = 18.5-24.9 kg/m2) and 
overweight (BMI = 25.0 – 29.9 kg/m2)  as recommended by CDC(49). 
5.9.6. Quality assurance 
A pre-test was done in Kombolcha town on 20 (5%) homeless individuals who were similar with 
study participants prior to the data collection to check the clarity and consistency of the 
questionnaires and acceptability of laboratory procedure. Necessary correction was taken before 
the actual data collected. The data collectors, who can speak the local language (Amharic), were 
trained for one day on data collection procedures for this study to attain standardization and 
maximize interview reliability.  
The purpose of the study was informed to study participants for the quality of the data. In addition 
the study participants were instructed on how to produce appropriate sputum specimen. 
Instruments and reagents were checked for reliability and reproducibility of the test before any 
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test started. All new lots of reagents were tested with known positive and negative control. All 
positive microscopy slides and 10% percent of negative slides were double checked by second 
experienced laboratory technologists for confirmation. 
The data collections, application of standard laboratory test procedure and test result were 
checked by senior laboratory technologist and principal investigator. Filled questionnaire and 
laboratory test result were collected after checking consistency and completeness. The overall 
data collection process was supervised by principal investigator.  
5.10. Data processing and analysis 
Following the data collection, data were checked, coded and entered using EPI-INFO version 3.5 
and exported to SPSS version 20 for analysis. Both descriptive and analytical statistical 
procedures were utilized. Descriptive statistics like percentage, mean and standard deviation were 
used for presentation of data and prevalence of smear positive PTB and MDR-TB. Table and 
graphs were also used for data presentation. All variables of the study were initially tested for 
association with smear positive PTB by using binary logistic regression model. Those variables 
which have p-value less than 0.2 by binary logistic regression were put in the multivariable 
analysis model to control the possible effect of confounders. Finally the variable which has 
independent association with smear positive PTB was identified on the basis of odd ratio (OR) 
with 95% confidence interval (CI) and P-value less than 0.05. The variable was entered to 
multivariate model using the forward stepwise (likelihood ratio) regression method. Model fitness 
was checked using Hosmer and Lemeshow goodness of a fit test (0.70).  
5.11. Ethical clearance 
Primarily, ethical clearance was obtained from ethical review board of School of Biomedical and 
Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar. Then 
official permission letters were obtained from Dessie and Debre Birhan towns’ administrative 
body. Written informed consent was obtained from all study participants after adequate 
information about the potential benefits and risks of the study had been provided. Those 
participants with positive results for smear positive PTB and /or HIV infection were referred to 
the nearby health facility. Health education was also given for positive participants to prevent 
spread of infection to others. The collected data were kept confidentially by using anonymous 
instead of any personal identifiers. 
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5.12. Dissemination of results 
The finding of this study will be communicated to the School of Biomedical and Laboratory 
Sciences, College of Medicine and Health Sciences, University of Gondar, Dessie and Debre 
Birhan towns’ administrative body, Amhara Regional Health Bureau and Federal Ministry of 
Health. The research finding will be presented at different scientific conference and finally the 
manuscript will be prepared for publication in a standard journal. 
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6. Results 
6.1. Socio-demographic characteristics of the study participants 
A total of 351 study participants were participated in this study giving a response rate of 91.17%. 
Thirty four (8.83%) participants were unable to produce sputum and/or provided incomplete 
information. Out of the total study participants 190(175 males and 15 females) were from Dessie 
town that constituted 54.13% of the total participants and 161 (139 males and 12 females) were 
from Debre Birhan town that comprised 45.87% of the total participants. Among the total study 
participants, majority 324(92.7%) were male and 333(95.9%) were between 15-44 years of old. 
The mean age of the participants were 26.70 (SD + 7.96). About 163 (46.4%) of the study 
participants were illiterate and 180 (51.3%) of the study participants had primary school (1-8 
grade) education level.  Most of the participants 308 (87.7%) were single and 301(85.7%) of the 
participants were follow Orthodox Christians religion (Table1). 
Table 1. Socio-demographic characteristics of homeless individuals with smear positive PTB 
prevalence, Dessie and Debre Birhan towns, Northeast Ethiopia, 2015(N = 351). 
Variables                     Label                  Smear positive PTB                            Frequency N (%) 
                                                                 Negative n (%)       Positive n (%)    
Age                             15-24                       158(98.1)                  3 (1.9%)                   161 (45.9) 
                                    25-34                       138 (97.2)                 4 (2.8)                      142 (40.5) 
                                    35-44                       28(93.3)                    2 (6.7)                      30 (8.5) 
                                    45-60                       18 (100)                    0 (0)                         18 (5.1) 
Sex                              Male                        316(97.5)                  8 (2.5)                      324 (92.3) 
                                    Female                     26(96.3)                   1 (3.7)                       27 (7.7) 
Marital status            Single                      300(97.4)                  8 (2.6)                      308 (87.7) 
                                    Married                   11(91.7)                    1 (8.3)                      12 (3.4) 
                                    Divorced                 17(100)                     0 (0)                         17 (4.8) 
                                   Widowed                 14(100)                      0 (0)                         14 (4.0) 
Educational status     Illiterate                      158(96.9)                     5 (3.1)                          163 (46.4) 
                                      Primary                       176(97.8)                     4 (2.2)                          180 (51.3) 
                                      Secondary                    8(100)                         0 (0)                              8 (2.3)   
Religion                        Orthodox                     293(97.3)                     8 (2.7)                          301 (85.8) 
                                      Muslim                        47(97.9)                       1 (2.1)                          48 (13.7) 
                                      Protestant                     2(100)                          0 (0)                             2 (0.6)  
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6.2. Behavioral  characteristics of the study participants 
Out of the total study participants 169 (48.1%) were smoke cigarette during the study periods, of 
these, 67 (39.6%) were smoke regularly for greater than 5 years. The mean smoking periods of 
the participants were 64.70 (SD + 43.59) months. Two hundred sixty three (74.9%) participants 
were drunk alcohol during the study periods of whom 164 (62.4%) were drunk regularly for 
greater than 5 years. The mean alcohol drinking periods of the participants were 81.86 (SD + 
56.85) months. More than half of the respondents 195(55.6%) were chew khat during the study 
periods, of whom 89 (45.6%) were chew regularly for greater than 5 years. The mean khat 
chewing periods of the participants were 64.07 (SD + 46.22) months.  About 10 (2.8%) of the 
participants were use drug during the study periods (Figure 1). 
 
Figure 1.  Presence of behavioral characteristics of homeless individuals with smear positive PTB 
prevalence, Dessie and Debre Birhan towns, Northeast Ethiopia, 2015 (N=351). 
6.3. Environmental  factors of the study participants 
 The participants mean duration of being homelessness was 65.92(SD + 49.16) months and about 
148 (42.2%) of the participants were homelessness for greater than 5 years.  The average number 
of homeless individuals slept/ live together in one restricted homeless shelter were 5 (SD + 2.99) 
and almost half 163 (46.4%) of the participants were slept/ lived together in one restricted 
homeless shelter by being more than 5 persons. Among the study participants 17 (4.8%) and 114 
(32.5%) had close contact with known TB patients and chronically cougher patients respectively 
(Table 2).  
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Table 2. Environmental factors of homeless individuals with smear positive PTB prevalence, 
Dessie and Debre Birhan towns, Northeast Ethiopia, 2015(N=351). 
Variables                                                     Label    Smear positive PTB          Frequency N (%)       
                                                                                     Negative n (%) Positive n(%) 
Duration of being homelessness                      > 5 years           141(41.2)          7(77.8)               148 (42.2) 
                                                                           <   5 years          201(58.8)          2(22.2)               203 (57.8) 
Average number of homeless  
individuals slept/ lived together               > 5 persons         157(45.9)         6(66.7)               163 (46.4) 
                                                                           <   5 persons       185(54.1)         3(33.3)               188 (53.6) 
Close contact with known TB patients    Yes                   15(4.4)           2(22.2)             17 (4.8) 
                                                                     No                    327(95.6)       7(77.8)             334 (95.2) 
Close contact with chronically cougher  Yes                   108(31.6)       6(66.7)            114 (32.5) 
                                                                     No                    234(68.4)       3(33.3)            237 (67.5) 
6.4. Morbidity history and status of the study participants 
Out of the total study participants 85(24.2%) participants were had chest pain, followed by 
difficulty of breathing 79(22.5%) and night sweating 67(19.1%) (Figure 2. ).  
 
Figure 2. Presence of PTB suggestive symptoms among homeless individuals with smear positive 
PTB prevalence, Dessie and Debre Birhan towns, Northeast Ethiopia, 2015 (N=351). 
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Out of the total study participants 10(2.8%) participants had past history of TB disease, all of 
these were diagnosed during being homelessness and  all were start anti-TB treatment but  more 
than half  of them 6 (60%) were defaulted anti-TB treatment. Out of the total study participants 25 
(7.1%) participants were malnourished, BMI less than 18.5. Out of the total study participants 22 
(6.3%) participants were HIV infected (Table 3).   
Table 3.  Morbidity history and status of homeless individuals with smear positive PTB 
prevalence , Dessie and Debre Birhan towns, Northeast Ethiopia, 2015(N = 351) 
Variables                               Label               Smear positive PTB                     Frequency N (%) 
                                                                        Negative (%)       Positive (%)      
Past history of TB                    Yes                      9(2.6)                      1(11.1)                            10 (2.8) 
                                                   No                       333(97.4)                 8(88.9)                           341 (97.2) 
Past anti- TB treatment          Defaulted            5(55.6)                     1(100)                             6 (60) 
                                                   Completed           4(44.4)                    0(0)                                4 (40) 
BMI (kg/m
2
)                             < 18.5                20(5.8)                  5(55.6)                        25(7.1)                       
                                                   > 18.5                322(94.2)             4(44.4)                         326 (92.9) 
HIV antibody                       Reactive            17(5)                    5 (55.6)                        22 (6.3)                                       
                                               Non reactive     325(95)                4(44.4)                         329 (93.7)                            
    
6.5. Prevalence of smear positive pulmonary tuberculosis and multi-drug resistant 
tuberculosis in homeless individuals 
Out of the total study participants, smear positive PTB was detected in 9 of the participants (8 
males and 1 female) by LED-FM. All smear positive PTB sputum specimen were further 
analyzed by GeneXpert assay, the assay confirmed that all were positive for MTBC but none 
were resistant to RIF. Therefore, the prevalence of smear positive PTB was 2.6% (95% CI: 1.3%, 
5%) among the study participants. The point prevalence of smear positive PTB was extrapolated 
to be 505/100,000 homeless individuals. All smear positive PTB cases are found in the age group 
(17 – 44 years) of the participants. About 8(88.9%) smear positive PTB cases were found in the 
study participants who smoke cigarettes, drink alcohol and chew khat during the study periods. 
Five (55.5%) smear positive PTB cases are found in the study participants who were 
malnourished during the study periods. In addition among the total smear positive PTB 
participants, 5(55.5%) were co-infected with HIV infection. 
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6.6. Factors associated with smear positive tuberculosis in homeless individuals  
Bivariate logistic regression analysis showed that there were statistically significant association 
between smear positive PTB and smoking, smoking cigarette regularly for greater than 5 years, 
chewing chat regularly for greater than 5 years, being homelessness for greater than 5 years, close 
contact with known TB patients, close contact with chronically cougher patients, chest pain, 
difficulty of breathing, weight loss, night sweating, BMI less than 18.5 and HIV infection. 
However, smoking cigarette regularly for greater than 5 years, BMI less than 18.5 and HIV 
infection were had statistically significant association with smear positive PTB in multivariable 
logistic regression after controlling the effect of confounder.  
 Multivariate analysis reviled that, participants who smoke cigarette regularly for greater than 5 
years were 10.08 times more likely to have  smear positive PTB  than those  who smoke cigarette 
regularly for less than 5 years [AOR =10.08, 95% CI: 1.04, 97.66]. The study also showed that 
statistically significant association between smear positive PTB and BMI.  Participants who had 
BMI less than 18.5 were 6.94 times more likely to have  smear positive PTB as compared to  
those who had BMI greater  than 18.5 [AOR =6.94, 95% CI: 1.17, 41.07]. Furthermore, HIV 
infected homeless individuals were 6.75 times more likely to have smear positive PTB than those 
HIV uninfected homeless individuals [AOR =6.75, 95% CI: 1.14, 40.07] (Table  4).  
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Table 4. Factors associated with smear positive pulmonary tuberculosis in homeless individuals 
(bivariate and multivariate analysis) in Dessie and Debre Birhan towns, Northeast Ethiopia, 2015  
Variables                                            Smear positive PTB   COR (95% CI)    AOR (95% CI)   p- value 
                                                             Negative     Positive                                                           
Smoking   cigarette                        
Yes                                                             161         8          8.99(1.11-72. 69)*      _________           _____ 
No                                                              181         1          1         
Smoking duration    
Greater than 5 years                                   60           7          11.78(1.41-98.12)*   10.08(1.04-97.66)*   0.046 
Less than 5 years                                       101          1          1                                1 
Khat chewing 
Yes                                                             187         8          6.63(0.82-53.6)           ____________         ____ 
No                                                              155         1          1   
Khat chewing duration     
Greater than 5 years                                   82           7          8.96(1.08 -74.31)*       ___________       _____ 
Less than 5 years                                       105          1          1   
Drug using  
Yes                                                             8             1          4.62(0.52-40.98)         ___________         _____ 
No                                                              334         8          1 
Duration of being homelessness   
Greater than 5 years                                   141         7          4.99 (1.02-24.37)*      ___________         _____ 
Less than 5 years                                        201         2          1  
Close contact with known TB patients           
Yes                                                             15           2           6.23(1.19-32.58)*       ___________      _____ 
No                                                               327        7           1   
Close contact with chronically cougher  
Yes                                                             108         6           4.33(1.06- 17.65)*       ___________       _____ 
No                                                               234        3          1        
Chest pain                               
Yes                                                             80           5          4.09 (1.07 – 15.61)*      ____________     ____ 
No                                                              262         4           
Difficulty of breathing  
Yes                                                            74            5          4.53 (1.19 – 17.28)*     ___________       _____ 
No                                                              268         4          1   
Weight loss  
Yes                                                             35           4          7.02(1.80 -27.35)*      ____________       ____ 
No                                                              307         5          1  
Night sweating   
Yes                                                             62           5          5.64 (1.47- 21.63)*     ____________       _____ 
No                                                              280         4          1     
Loss of appetite 
Yes                                                             53           3          2.72(0.66-11.24)         ____________       _____ 
No                                                              289         6           1 
Past TB history   
Yes                                                             9             1          4.62(.52-40.98)         ____________         _____ 
No                                                              333         8          1 
BMI 
Less than 18.5                                            20           5         20.12(5.01–80.81)*    6.94 (1.17 –41.07)*  0.033 
Greater than 18.5                                       322         4           1                                  1 
HIV anti - body  
Reactive                                                     17           5          23.89 (5.88–97.13)*  6.75(1.14 – 40.07)*  0.036 
Non reactive                                              325         4          1                                  1 
* Statistically significant variable to smear positive PTB which, p- value less than 0.05 
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7. Discussion 
This study showed that the prevalence of smear positive PTB among TB suspect homeless 
individuals was 2.6%. This finding is in line with studies conducted  in USA (3.28%)(33), 
Japan(1.5%)(29) and Rome (3.86%)(39). The finding is also supported by systematic review and 
meta-analysis of prevalence of active TB among homeless individuals, estimated to be 0.2–
7.7%(19).  In this study all TB cases are found in young and productive age group (17– 44 years) 
of the participants. This finding is similar to the developing world TB rates, highest among young 
adults which leads to grave socio-economic consequences in a country(7). This high TB burden 
may also attribute to an aggressive transmission of TB in the homeless individuals and to the 
surrounding community. 
Moreover, TB prevalence in this study is to some extent higher than studies conducted among 
homeless individuals in Marseilles (1%)(37) and Iran (1.2%)(27). The relatively lower prevalence 
of TB in those countries could be due to high socio-economic status and low overall TB 
prevalence in the countries. In addition relatively lower prevalence of TB in Iran might be due to 
lower prevalence of HIV infection (3.4%)(27).   
However, TB prevalence in this study is lower than studies conducted among homeless 
individuals in USA (6.1%)(32), Seoul, South Korea (24.86%)(24), North-eastern Poland 
(4.13%)(40) and Colombia (7.9%)(38), the difference might be due to difference in study design 
and setting, sample size and laboratory diagnosis method used. In USA the analysis was covered 
a wide geographic area with large sample size and the cases were either smear positive PTB or 
culture confirmed other form of TB(32).  On the other hand in South Korea the prevalence of 
active TB was not based on sputum smear AFB but, it is  based on chest radiography(24) this 
could be over sensitive and not specific enough as FM thus might be increase the prevalence 
of TB than this study. In North-eastern Poland, the participants were first screened by chest 
radiography, then molecular testing and culture were performed(40), the use of an advanced 
diagnosis technique might be not underestimated the actual prevalence. In Colombia all reported 
case are culture positive for MTB(38), could be revealed all types of TB in addition to smear 
positive PTB.  
Several studies indicated that higher prevalence of TB in homeless individuals than the general 
population (29, 35, 41). For example,  in USA compared to the general population, homeless 
individuals had an approximately 10-fold increase in TB prevalence(34). Extrapolation of this 
study finding also indicated that about 4.67 times high burden of smear positive PTB in homeless 
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individuals than the general population (108/100,000) in Ethiopia(42). This study point 
prevalence of smear positive PTB is comparable with  study conducted in Greater London 
(780/100,000)(41). Furthermore despite the overall decline TB incidence in the general 
population, 28 outbreaks of TB occurred in Illinois among homeless individuals,  indicating that 
ongoing transmission of TB  to the homeless individuals and the entire community(36). These 
disproportionate burden of TB in homeless individuals might be due to that these groups are the 
most neglected and live in under-privileged social conditions such as poverty, malnutrition and 
overcrowd unhygienic environment with relatively limited access to health care(21). 
In this study MDR-TB was not found. However, studies conducted in USA(2.7%)(32), 
USA(1.1%)(34), Busan Medical Center, Korea (11.5%)(21) and London(6.5%)(41) MDR–TB 
was found among homeless individuals. Absence of MDR-TB in this study might be due to the 
small number of smear positive PTB cases enrolled in the study. However well known risk factors 
for the development of MDR-TB, previous anti-TB treatment defaulter rate is high (60%) in this 
study.  
In this study participants who smoke cigarette regularly for greater than 5 years were 10.08 times 
more likely to have smear positive PTB than those who smoke cigarette regularly for less than 5 
years. Even though there was no other studies considered duration of smoking in homeless 
individuals, the role of smoking in the development of active TB is well established(50) either 
trough increased susceptibility to new infection with MTB or increase the  risk of developing 
active TB(51). Thus, increasing duration of smoking might be increase the development of TB 
disease. Smoking cigarette by itself were reported as a risk factor for acquisition of active TB in 
Rome(39) and  Montreal, Canada (43) but in this study it was not significantly associated. 
However, in this study about 88.9% smear positive PTB cases were found among cigarette 
smokers.  
In addition this study showed that participants who had BMI less than 18.5 were 6.94 times more 
likely to have smear positive PTB as compared to those who had BMI greater than 18.5. This 
finding also supported by studies conducted in Seoul, South Korea(24) and Rome(39). This might 
be due to that since malnutrition is adversely affects the immune status of individuals, it makes 
individuals more susceptible to TB infection and progression of active TB disease (52).  
This study also showed that HIV infected homeless individuals were 6.75 times more likely to 
have smear positive PTB than those HIV uninfected homeless individuals. This finding is in line 
with studies conducted in USA(32, 33) and Montreal, Canada(43). This might be due to that HIV 
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infection often leads to a greater rate of TB either through reactivation or increased susceptibility 
to new infection with MTB thus, the main driving factor which aggravates TB. The life time risk 
of HIV infected individuals to develop TB is 20-37 times higher  than HIV uninfected 
individuals(5). In addition in this study HIV infection was found in 22 (6.3%) of the study 
participants. This high HIV burden might be due to risky behaviors of homeless individuals to 
acquire the disease. In this study TB - HIV co-infection were also considerably high (55.56%).  
In contrast to studies conducted in USA(32), Rome (39) and Montreal, Canada(43), in this study 
alcohol drinking was not significantly associated with smear positive PTB. The reason might be 
more or less homeless individuals in this study exhibit similar alcohol drinking characteristics 
(about three quarter of the participants were drunk alcohol during the study periods), this might 
reduce the individual variation and make it difficult to see its  effect  on outcomes of smear 
positive PTB. However, about 88.9% smear positive PTB cases are found among alcohol drinker 
study participants during the study periods. In addition, in contrast to study conducted in Seoul, 
South Korea(24), in this study past history of TB disease is not significantly associated with 
smear positive PTB. The reason might be participants who had past history of TB disease were 
small in number in this study, might be not enough to show the effect of past history of TB on 
smear positive PTB. 
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8. Limitations of the study 
Lack of adequate published data on developing country TB prevalence among homeless 
individuals make the comparison limited. Furthermore, the information on socio-demographic, 
behavioral, environmental factors and morbidity history were self- reported; homeless individuals 
might be less likely to recall such information accurately. Another limitation of the study was the 
difficulty of addressing more mobile homeless individuals. The GeneXpert test was not done for 
all study participants
,
 sputum samples, this might be underestimated the actual prevalence of 
MDR-TB. The cross-sectional nature of the study limits the degree to assign causality, especially 
with respect to temporality. It is a quantitative study which was not supported by qualitative data.   
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9. Conclusion  and recommendation 
9.1. Conclusion 
The prevalence of smear positive PTB among TB suspect homeless individuals was high. 
Extrapolation of this study finding also indicates that the point prevalence of smear positive PTB 
in homeless individuals was 4.67 times higher than the general population in Ethiopia. It indicates 
that there is high transmission of TB in the homeless individuals and also become a risk to the 
entire community. Although MDR-TB was not found, well known risk factors for MDR-TB, 
previous anti-TB treatment defaulter rate is high in these study participants. Smoking cigarette 
regularly for greater than 5 years, malnutrition and HIV infection were significantly associated  
factors with smear positive PTB among homeless individuals.  
9.2. Recommendations  
For Federal Ministry of Health  
 Special emphasis is needed for homeless individuals to exert intensive effort to identify 
undetected TB cases to limit circulation of disease in to the community. 
 Developing and implementing specific TB prevention and control strategies with integrated 
risk reduction approach is needed for homeless individuals. 
For Dessie and Debre Birhan towns
, 
Health office 
 Conducting an active surveillance of TB is needed, to identify early infectious cases and to 
reduce prolonged transmission of the disease in the homeless individuals and to the 
community.  
 Appropriate health education should be given for homeless individuals to control the spread 
of TB and to reduce associated risk factors that aggravate TB.  
 Careful follow-up is needed for homeless individuals during anti-TB treatment to prevent the 
emergence of MDR–TB. 
 Providing HIV testing and counseling to homeless individuals is needed. 
For researchers 
 Further research is needed to reinforce and explore the prevalence and associated factors of 
TB and MDR-TB among homeless individuals in depth with large sample sizes and advanced 
diagnostic techniques. 
 Further studies should be conducted to assess the impact of homelessness on TB, MDR-TB 
and TB-HIV co-infection in different geographical area with both qualitative and quantitative 
approach.  
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11. Annexes 
Annexes 1: Information sheet and consent form 
 Information sheet  
Good morning/good afternoon. My name is ________. I am working here on behalf of Tsedale 
Semunigus, student of Medical Microbiology in the University of Gondar. She is conducting a 
research for the partial fulfillment of the requirement for master’s degree in Medical 
Microbiology. She has received permission from institutionalized research review board, School 
of Biomedical and Laboratory Sciences at University of Gondar and Dessie and Debre Birhan 
town administrative body to conduct this study. I would like to invite  you to participate in this 
research project.  
Title of the research project 
Prevalence and associated factors of smear positive pulmonary tuberculosis and multi drug 
resistant tuberculosis among homeless people in Dessie and Debre Birhan town, Northeast 
Ethiopia 
Name of principal investigator: Tsedale Semunigus 
Name of the organization: School of Biomedical and Laboratory Sciences, College of Medicine 
and Health Sciences, University of Gondar 
 Name of the sponsor: Amhara Regional Health Bureau 
 Introduction 
This information sheet and consent form is prepared with the aim of explain the research project 
that you are asked to join by the group of research investigators. The main aim of this research 
project is to assess the prevalence and associated factors of smear positive pulmonary tuberculosis 
and multi drug resistant tuberculosis among homeless people in Dessie and Debre Birhan town, 
northeast Ethiopia. The research group includes trained two laboratory technologist, two nurse, 
principal investigator and two advisors from University of Gondar. 
 Purpose of the research project 
The aim of this study is to assess the prevalence and associated factors of smear positive 
pulmonary tuberculosis and multi drug resistant tuberculosis among homeless people in Dessie 
and Debre Birhan town, northeast Ethiopia. Smear positive TB and MDR TB in homeless people 
is a major public health problem. Prevalence of tuberculosis is high in our country where there is 
overcrowding, malnutrition, past exposure to TB and other underlying health problems sush as 
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HIV. However, the prevalence and associated factors of smear positive pulmonary tuberculosis 
and multi drug resistant tuberculosis among homeless people has not yet determined in Ethiopia. 
The result of this study will be used as a basis, especially in the study area to design appropriate 
intervention towards TB and MDR TB and their associated risk factors. 
 Procedure 
To assess the prevalence and associated factors of smear positive pulmonary tuberculosis and 
multi drug resistant tuberculosis among homeless people in Dessie and Debre Birhan town, we 
invite you to take part in our project. If you are willing to participate in this project, you need first 
understand and sign the agreement form. Then you will be asked to give your response and 
sputum and blood samples by the data and specimen collectors respectively. For participants who 
are not capable of giving response or specimen, they will be exempted. For this questionnaire and 
specimen based study, participant are all those homeless people living in the study town. All the 
response given by the participants and laboratory result obtained will be kept confidential using 
coding system whereby no one will have access to your response except the principal investigator.  
 Risk and discomfort 
By participating in this research project, you may fill that it has some discomfort especially on 
wasting your time 15 minute for questionnaire response, and for sputum specimen 10 minute for 
three times in two consecutive days and 30 minute for blood specimen. But these will not be too 
much as compared with the benefits. No risk in participating in this study project. 
 Benefits 
If you participate in this research project, you will be benefited from free diagnosis, treatment and 
advice depending on your result. Moreover your participation is likely to help us in identifying 
the gap and will have the benefit of improving strategies to prevent PTB, MDR TB and associated 
factors among homeless individuals. 
Incentives 
 You will not be provided any incentive or payment to participate in this project. 
Confidentiality 
The information that we collect from this research project will be kept strictly confidential. 
Information about you that will be collected from the study will be handled in a file, which will 
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not have your name on it, but the code number assigned to it. It will not accessible to anyone 
except the principal investigator. 
Right to refuse  
You have full right to refuse from participating in this research project and you can choose not to 
respond some or all questionnaire and giving specimen. If you do not wish to participate in this 
study,  will not affect any service on health institution. 
 Whom to contact 
This research project will be received and approved by ethical committee and School of 
Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University Of 
Gondar. If you have any question, contact any of the following individuals and you may ask at 
any time you want. 
1. Tsedale Semunigus (B.Sc), mobile 09163724810, Email address tsedalesemu@gmail.com 
2. Prof. Feleke Moges (PhD), mobile 0918778160, Email address Mogesfeleke@gmail.com 
3. Dr Belay Tessema (PhD), mobile 0919306918, Email address bt1488@yahoo.com 
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Consent form 
I the undersigned individual has been well informed about the objectives of the study entitled on 
prevalence and associated factors of smear positive pulmonary tuberculosis and multi drug 
resistant tuberculosis among homeless individuals in Dessie and Debre Birhan towns, Northeast 
Ethiopia. I am also told that all information obtained at any course of the study is to be kept 
confidential. More over I have also been well informed of my right to keep hold of, decline to 
cooperate and drop out of the study if I want. Therefore, with full understanding of the 
information sheet, I   voluntarily consent to participate in the study.  
Respondent code                sign                 Date 
 ___________                     ______            _____ 
Data collector name              sign                 Date 
_______________               _____            _______ 
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Annex 2: Amharic version of information sheet and consent form 
የ መረጃ ቅፅ 
ዯህና አዯራችሁ/ዋሊችሁ፡ ፡ ስሜ------------------ ይባሊሌ፡ ፡  በአሁኑ ሰአት በጎ ንዯር ዩንቨርሲቲ በሜዱካሌ 
ማይክሮባዮልጂ የ ድህረ ምረቃ ተማሪ ከሆነ ችው ፀዲሇ ሰሙንጉስ ጋር አብሬ እሰራሇሁ፡ ፡  የ ድህረ ምረቃ ሂዯቱን ሇማማሊት 
ጥናት እያካሄዯች ሲሆን ከጎ ንዯር ዩኒቨርሲቲ  የ ስነ ምግባር ኮሜቴና የ ባዮሜዱካሌና ሊቦራቶሪ ሳይንስ ትምህርት ክፌሌ እና 
ከዯሴ እና ዯብረብርሃን ከተማ መስተዲድር አካሊት ፇቃድ አግኝታሇች፡ ፡   
የ ምርምሩ/ጥናቱ ርዕስ 
በአክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና ብዙ መድሃኒቶችን የ ተሊመዯ ቲቢ በሽታ ስርጭትና ተያያዥነ ት ያሊቸው ነ ገ ሮች 
በዯሴና ዯብረብርሃን ከተማ፣ ሰሜንምስራቅ ኢትዮጵያ በሚኖሩ የ ጎ ዲና ተዲዲሪዎች  
የ ዋና ተመራማሪው ስም፡   ፀዲሇ ሰሙንጉስ 
የ ድርጅቱ ስም፡  ጎ ንዯር ዩንቨርሲቲ የ ባዮሜዱካሌ እና ሊቦራቶሪ ሳይንስ ትምህርት ክፌሌ 
የ ስፖንሰር ድርጅቱ ስም፡  የ አማራ ክሌሊዊ መንግስት ጤና ጥበቃ ቢሮ 
መግቢያ  
ይህ የ መረጃና የ ስምምነ ት ቅፅ ውሌ የ ተዘጋጀው እርስዎ ተሳታፉ እንዱሆኑ ስሇተጋበዙበት በምርምር ቡድኑ  የ ሚካሄዯውን 
ጥናት በተመሇከተ መግሇጫ ሇመስጠት ነ ው፡ ፡  የ ምርምር ፕሮጀክቱ ዋና አሊማ በአክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና 
ብዙ መድሃኒቶችን የ ተሊመዯ ቲቢ በሽታ ስርጭትና ተያያዥነ ት ያሊቸው ነ ገ ሮች  በዯሴና ዯብረብርሃን ከተማ፣ ሰሜንምስራቅ 
ኢትዮጵያ በሚኖሩ የ ጎ ዲና ተዲዲሪዎች ሊይ ማጥናት ነ ው፡ ፡ የ ምርምር ቡድኑ ሇዚህ ጥናት የ ሰሇጠኑ ሁሇት የ ድግሪ  ሊቦራቶሪ 
ሳይንስ  ባሇሙያዎች፣  ሁሇት ነ ርሶች፣  ዋና ተመራማሪዋንና ሁሇት አማካሪዎች ከጎ ንዯር ዩንቨርሲቲ ያካተተ ነ ው፡ ፡  
የ ጥናቱ አሊማ 
የ ዚህ ጥናት አሊማ በአክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና ብዙ መድሃኒቶችን የ ተሊመዯ ቲቢ በሽታ ስርጭትና 
ተያያዥነ ት ያሊቸው ነ ገ ሮች በዯሴና ዯብረብርሃን ከተማ፣ ሰሜንምስራቅ ኢትዮጵያ በሚኖሩ የ ጎ ዲና ተዲዲሪዎች ሊይ ማጥናት 
ነ ው፡ ፡  በአክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና ብዙ መድሃኒቶችን የ ተሊመዯ ቲቢ በጎ ዲና ተዲዲሪዎች ሊይ መኖር 
የ ህብረተሰብ የ ጤና ችግር ነ ው፡ ፡ የ በሽታው ስርጭት በሀገ ራችን፤  በተሇይም መተፊፇን፣  የ ምግብ እጥረት፣ ከዚህ በፉት ሇቲቢ 
የ መጋሇጥ ሁኔታና ላልች በሽታውን የ ሚያባብሱ የ ጤና ችግሮች እንዯ ኤች አይቪ ያለ ሁኔታዎች  በሚኖሩበት ጊዜ ከፌተኛ 
ነ ው፡ ፡  ይሁንና በኢትዮጵያ በጎ ዲና ተዲዲሪዎች  ሊይ የ በሽታው ስርጭትና ተያያዥነ ት ያሊቸው ነ ገ ሮች  ዙሪያ እስከአሁን 
የ ተጠና ጥናት የ ሇም፡ ፡  የ ዚህ ጥናት ውጤት የ ሳንባ ቲቢና ብዙ መድሃኒቶችን የ ተሊመዯ ቲቢና ተያያዥነ ት ያሊቸው ነ ገ ሮች 
ሊይ ተገ ቢውን የ መከሊከሌ ስራ አቅዶ ሇመስራት በተሇይም ጥናቱ በሚካሂያዯበት ቦታ እንዯመነ ሻ  ሃሳብ ሉጠቅመን ይችሊሌ 
፡ ፡  
የ አሰራር ሂዯት 
የ አክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና ብዙ መድሃኒቶችን የ ተሊመዯ ቲቢ በሽታ ስርጭትና ተያያዥነ ት ያሊቸው ነ ገ ሮች 
በጎ ዲና ተዲዲሪዎች ሊይ ያሇውን ችግር ሇማወቅ  ይረዲ ዘንድ በዚህ ጥናት እንዱሳተፈ ጋብዘንዎታሌ፡ ፡ በዚህ ጥናት 
እንዱሳተፈ ከተስማሙ ስምምነ ቱን መረዲትና መፇረም ይኖርብዎታሌ፡ ፡  በዚህ ጥናት ሲሳተፈ መረጃ ሰብሳቢው የ ሚጠይቀውን 
ጥያቄና የ አክታና የ ዯም ናሙና እንዱሰጡ ፇቃዯኝነ ትዎ  ይጠየ ቃሌ፡ ፡ በህመም ወይም  በላሊ ምክንያት መሳተፌ  ካሇቻለ  
አይገ ዯደም:: በዚህ ጥናት የ ሚሳተፈት  በዯሴና ዯብረብርሃን ከተማ የ ሚኖሩ የ ጎ ዲና ተዲዲሪዎች ሲሆኑ የ ሚሰጡት መሌስም 
ሆነ  የ አክታና የ ዯም ናሙና  ውጤት በሚስጥር ይጠበቃሌ፤ ከዋና ተመራማሪው በስተቀር ማንም በማይዯርስበት  ቦታ በኮድ 
ይቀመጣሌ፡ ፡  
አዯጋዎችና አሇመመቸት  
በዚህ ጥናት መሳተፌዎ ምናሌባት የ ተወሰነ  ያሇመመቸት ሉሰማዎ ይችሊሌ፡ ፡  በተሇይም ጊዜዎትን ጥያቄዎችን  ሇመመሇስ 20 
ዯቂቃ፣  አክታ ሇመስጠት 10 ዯቂቃ ሇሶስት ጊዜ በሁሇት ተከታታይ ቀናትና የ ዯም ናሙና ሇመስጠት  30 ዯቂቃ ሉሻማዎ 
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ይችሊሌ ፡ ፡ ነ ገ ር ግን ጥናቱ ከሚሰጠው ጥቅም አንጻር ይህን  ያህሌ አይዯሇም፡ ፡ በዚህ ጥናት መሳተፌ ምንም አይነ ት አዯጋ 
የ ሇውም ፡ ፡  
ጥቅሞች 
በዚህ ጥናት በመሳተፌዎ  በነ ፃ  ሉመረመሩና በምረምራ ዉጤትዎ መሰረት ሉታከሙና ምክር ሇሰትዎት ይችሊሌ፡ ፡  ከዚህ በበሇጠ 
የ እርስዎ ተሳትፍ ሇእኛ በጎ ዲና ተዲዲሪዎች ሊይ በአክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና ብዙ መድሃኒቶችን የ ተሊመዯ 
ቲቢ በሽታ ስርጭትና ተያያዥነ ት ያሊቸው ነ ገ ሮች  ሊይ ያለትን ክፌትቶች ሇመሇየ ትና ሇማሻሸሌ ይጠቅመናሌ፡ ፡   
የ ተሳትፍ ማካካሻ 
በዚህ ጥናት በመሳተፌዎ  የ ሚሰጥ ማካካሻ ክፌያ የ ሇም፡ ፡  
ሚስጥር ስሇመጠበቅ 
በዚህ ጥናት የ ሚሰበሰበው  መረጃ በትክክሌ  ሚስጥራዊነ ቱ  ይጠበቃሌ፡ ፡  የ ሚሰበሰበው መረጃ የ እርስዎ ሇመሆኑ መሇያ 
አይኖረውም፡ ፡ መረጃው በዋና ተመራማሪው ፊይሌ ተዯርጎ  የ ሚቀመጥ በመሆኑ ላሊ ሰው ሉያገ ኘው አይችሌም፡ ፡  
በጥናቱ ያሇመሳተፌ ወይም እራስዎን ከጥናቱ የ ማግሇሌ መብት 
በጥናቱ ያሇመሳተፌ  እና  የ ማይመችዎትን ጥያቄ  በሙለ ወይም በከፉሌ መርጠው ያሇመመሇስና  ናሙና ያሇመስጠት ሙለ 
መብት አሇዎት፡ ፡  በጥናቱ ባሇመሳተፌዎ የ ሚያጡት የ ጤና ድርጅት አገ ሌግልት አይኖርም፡ ፡  
መረጃ ስሇማግኘት 
ይህ ጥናት  በጎ ንዯር ዩኒ ቨርሲቲ  የ ስነ ምገ ባር ኮሜቴና የ ባዮሜዱካሌና ሊቦራቶሪ ሳይንስ ትምህርት ክፌሌ ተከሌሶ 
የ ሚፀድቅ ይሆናሌ፡ ፡ ማንኛውም ጥያቄ ካሇዎት በፇሇጉት ሰአት በሚከተለት አድራሻዎች መገ ናኘት ይችሊለ፡ ፡  
1. ፀዲሇ ሰሙንጉስ        ስ. ቁ . 0963724810 ኢ.ሜሌ tsedalesemu@gmail.com 
2. ፕሮፋሰር ፇሇቀ ሞገ ስ  ስ. ቁ 0918778160 ኢ.ሜሌ Mogesfeleke@gmail.com 
3. ዶ/ር በሊይ ተሰማ      ስ.ቁ. 0919306918  ኢ.ሜሌ  bt1488@yahoo.com 
 
 
 
 የ ስምምነ ት ቅፅ 
እኔ ከዚህ በታች የ ፇረምኩት ግሇሰብ የ ጥናቱ ርእሱ በአክታ ምርመራ ፖዘቲቭ የ ሆነ  የ ሳንባ ቲቢና ብዙ መድሃኒቶችን 
የ ተሊመዯ ቲቢ በሽታ ስርጭትና ተያያዥነ ት ያሊቸው ነ ገ ሮች  በዯሴና ዯብረብርሃን ከተማ፣ ሰሜንምስራቅ ኢትዮጵያ በሚኖሩ 
የ ጎ ዲና ተዲዲሪዎች ሊይ ስሇሚሰራው ጥናት  አሊማና ጥቅሙን  በሚገ ባ ተረድቻሇሁ፡ ፡   በተጨማሪም በጥናቱ የ መሳተፌና 
ከጥናቱ በፇሇግሁት ጊዜ የ መዉጣት መብት እንዲሇኝ ተረድቻሇሁ፡ ፡  ስሇሆነ ም የ መረጃ ቅፁን በሚገ ባ ተረድቼ በሚሰራው ጥናት 
ሊይ በፇቃዯኝነ ት ሇመሳተፌ መወሰኔ ን ከዚህ በታች በፇረምኩት ፉርማዬ  አረጋግጣሇሁ :: 
 
  የ ተሳታፉው                           የ መረጃ ሰብሳቢው  
   ኮድ_____________                    ስም___________________  
   ፉርማ___________                    ፉርማ ________________  
   ቀን_____________                    ቀን_____________________ 
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Annex 3: Questionnaires  
 Code number___________Town _______________ Date__________ 
 Part I. Socio-demography characteristics 
No Questions Coding categories   
101     Sex 
 
0. Male  
1. Female  
102    Age       _________years   
103    Marital status 0. Single  
1. Married  
2. Divorced/Separated  
3. Widowed 
104  Educational status 0. Illiterate  
1. Primary (1-8 grade)  
2. Secondary(9-10 or 12 grade)  
3. College  (10+ or 12+)  
40 
 
105    Religion 0. Orthodox 
1. Muslim 
2. Protestant 
3. Others___________ 
Part II. Behavioral factors  
201 Do you smoke cigarette currently?   0. Yes 
1. No  
202 If   say yes for   how long smoke regularly?        _______ Months 
203 Do you drink alcohol currently?               0. Yes 
1.          1.  No 
204 If say yes for how long drink regularly?         _______ Months 
205 Do you chew khat currently? 0. Yes 
1. No 
206 If say yes   for how long chew regularly?          _______ Months 
207 Do you use drugs currently? 0.         0.  Yes 
1. 1.  No 
208 If say yes for how long use drugs regularly?          _______ Months 
Part III. Environmental factors 
301 How long did you live on the streets?       ________Months  
302 In average how many people live/sleep together 
in one restricted homeless shelter? 
      ________Persons  
303 Do you have close contact with known TB patient 
in same homeless shelter?  
0. Yes 
1. No  
304 Do you have close contact with chronically 
coughing person in same homeless shelter? 
0. Yes 
1. No 
Part IV. Morbidity history and status 
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401 Currently, what kind of TB suggestive 
symptoms (illness) do you have?  
 
 
N.B. Multiple choices possible. 
0. Cough > 2 weeks 
1. Chest pain  
2. Difficulty of breathing  
3. Fever  
4. Weight loss  
5. Night sweating  
6. Loss of appetite  
7. Malaise  
8. Fatigue  
402 Have you ever had TB disease?   0. Yes 
1. No 
403  If yes to Q.402, When have you been 
diagnosed for TB?   
0. During being homelessness 
1. Before being homelessness 
404  If yes to Q.402, did you take treatment?  0. No  
1. Yes 
405 If yes to Q.402, did you complete the full 
course of TB treatment?  
0. No 
1. Yes 
406 Weight (to be measured by data collector)           ______kg 
407 Height(to be measured by data collector)           ______meter 
408 Collected sputum (to will be   filled by 
data collector): make mark if taken.  
0. Spot 
1. Morning  
2. Spot 
409 Blood sample collected make mark if 
taken.  
0. Collected 
1. Not collected 
 Annex 4: Amharic version of the questionnaires 
 ከዚህ በታች ሊለት ጥያቄዎች መሌስዎን ይስጡ 
       ከተማ  ------------------  ቀን  -------------------- ኮድ-----------    
 ክፌሌ አንድ ፡ -ስሇማሀበራዊ  ኢኮኖሚያዊና ስነ ህዝብ ሁኔታን የ ሚመሇከቱ ጥያቄዎች 
ተ.ቁ ጥያቄዎች      ምርጫ 
101 ፆታ 0. ወንድ  
1. ሴት  
102 ዕድሜ         ______አመት 
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103 የ ጋብቻ ሁኔታ 0. ያሊገ ባ /ች 
1. ያገ ባ /ች 
2. የ ፇታ/ች 
3. የ ሞተባት/በት 
104 የ ትምህርት ዯረጃ  0. ያሌተማረ/ች 
1. የ መጀመሪያ ዯረጃ  የ ተማረ/ች (1-8ኛ ክፌሌ )  
2. ሁሇተኛ ዯረጃ የ ተማረ/ች (9-10 / 12ኛ ክፌሌ)  
3. ኮላጅ የ ተማረ/ች (10+ / 12+)  
105 ሀይማኖት 0. ኦርቶዶክስ 
1. ሙስሉም 
2. ፕሮቴስታንት 
3. ላሊ__________ 
ክፌሌ  ሁሇት፡ -  ከስነ  ምግባር  ጋር የ ተያያዙ ጉዲዮች 
201 በአሁኑ ስአት ሲጋራ ያጨሳለ ?   0. አጨሳሇሁ 
1. አሊጨስም  
202 አዎ ካለ ሇምን ያህሌ ጊዜ በመዯበኛ ሁኔታ አጭሰዋሌ ?  _____ወር 
203 በአሁኑ ስአት አሌኮሌ መጠጥ ይጠጣለ ?  0. እጠጣሇሁ 
1. አሌጠጣም  
204 አዎ ካለ ሇምን ያህሌ ጊዜ በመዯበኛ ሁኔታ ጠጥተዋሌ ?   _____ወር 
205 በአሁኑ ስአት ጫት ይቅማለ ? 0. እቅማሇሁ 
1. አሌቅምም 
206 አዎ ካለ ሇምን ያህሌ ጊዜ በመዯበኛ ሁኔታ ቅመዋሌ ?   ____ወር 
207 አዯንዛዥ እፅ ይጠቀማለ 0. አዎ 
1. አሌጠቀምም 
208 አዎ ካለ ሇምን ያህሌ ጊዜ በመዯበኛ ሁኔታ ተጠቅመዋሌ ?   ______  ወር 
 
ክፌሌ ሶስት፡ - ከአካባቢያዊ  ሁኔታዎች  ጋር  የ ተያያዙ  ጉዲዮች 
301 ሇምን ያህሌ ጊዜ በጎ ዲና ሊይ ኖረዋሌ ?    ______ ወር 
302 በጎ ዲና ሊይ በሚኖሩበት ጊዜ በአንድ በተወሰነ  ቦታ 
በአማካኝ ምን ያህሌ ሰዎች በአንድነ ት ይኖራለ/ይተኛለ? 
   _______ሰዎች      
 
303 ከታወቀ የ ቲቢ ህሙማን ጋር የ ቅርብ ግንኙነ ት አሇዎት በጎ ዲና ሊይ  
? 
0. አሇኝ 
1. የ ሇኝም  
304 ሇረጅም ጊዜ ከሚስሌ ሰው ጋር የ ቅርብ ግንኙነ ት አሇዎት በጎ ዲና 
ሊይ? 
0. አሇኝ 
1. የ ሇኝም 
ክፌሌ አራት፡   የ ህመም ታሪክና ሁኔታ 
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401 በአሁኑ ሰአት ምን አይነ ት የ ህመም  
ምሌክት ወይም ስሜት አሇብዎት/  
ይስማዎታሌ?  
 
 
 
ማስታወሸ፡  ብዙ ምርጫዎች ይቻሊሌ 
0. ሁሇት ሳምንትና ከዚያ በሊይ የ ቆየ  ሳሌ 
1. የ ዯረት ህመም 
2. የ መተንፇስ ችግር 
3. ትኩሳት 
4. ክብዯት መቀነ ስ 
5. በሇሉት ማሊብ 
6. የ ምግብ ፌሊጎ ት ምቀነ ስ 
7. ማቅሇሽሇሽ 
8. ድካም  
402 የ ቲቢ በሽታ ታመው ያውቃለ? 0. አዎ 
1. አሊውቅም 
403 መሌስዎ አዎ ከሆነ  (በጥያቄ ተ.ቁ 402)መቼ 
ነ ው ቲቢ የ ታመሙት?  
0. የ ጎ ዲና ተዲዲሪ ሆነ ው እያለ 
1. የ ጎ ዲና ተዲዲሪ ከመሆንዎ በፉት 
404  መሌስዎ አዎ ከሆነ  (ሇጥያቄ ተ.ቁ 402) 
የ ቲቢ መድሃኒት ወስዯዋሌ ?  
0. አሌወሰድኩም  
1. አዎ 
405 መሌስዎ አዎ ከሆነ  (ሇጥያቄ ተ.ቁ 404) 
መድሃኒቱን ሙለ በሙለ አጠናቀው ውስዯዋሌ? 
0. አሌወሰድኩም  
1. አዎ 
406 ክብዯት በመረጃ ሰበሳቢው ይሇካ  ______ኪ.ግራም 
407 ቁመት በመረጃ  ሰበሳቢው  ይሇካ  ______ሜትር 
408  አክታ መወሰደን ምሌክት ያድርጉ  
 
 
0. ወዱያውኑ  
1. ጠዋት  
2. ወዱያውኑ   
409 የ ዯም ናሙና መወሰደን ምሌክት ያድርጉ   0. ተወስዲሌ 
1. አሌተወሰዯም  
Annex 5: Procedure for sputum smear microscopy using Auramine O staining  
 Prepare the smears, let  air dry  and  fix it  by passing three times slowly through the flame 
 Arrange slides in serial order on staining rack, with smear side up, at a distance of at least 
1cm between every slide. 
 Flood slides with filtered 0.1% Auramine O solution, without heating. 
 Keep the staining reagent for 20 minutes.  
 Rinse with water and drain. 
 Apply decolorizing solution, 0.5% Acid alcohol, for 3 minutes. 
 Gently rinse with water until the macroscopically visible stain has been washed away and 
drained. 
 Flood smear with 0.5% potassium permanganate solution for 1 minute.  
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 Gently rinse with water and drain then air dry on a slide rack. 
 Keep stained smears in the box and read as soon as possible. 
 Using the 20x objective of fluorescence microscope to scan the stained smear 
systematically and 40x objective for confirmation of AFB.  Acid-fast bacilli appear bright 
yellow against the dark background material(45).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annex 6: GeneXpert MTB/RIF assay procedure 
 Sputum sample liquefaction and inactivation with 2:1 sample reagent buffer to sample 
ratio 
 Shake  and incubate  for  10  minutes  at  room temperature 
 Shake it  again and let it stand further for 5 minutes 
 Remove Xpert cartridge from its wrapper.  
 Label the side of the Xpert cartridge with the sample identification number.  
 Open the lid of the cartridge 
 Open the lid of the collection container containing the mixed sputum specimen 
 Transfer of 2ml sample into the open port of the cartridge 
 Close the cartridge lid firmly. 
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 Insert the cartridge and switch on the GeneXpert  instrument and start the test, End of 
hand work 
 Sample is automatically filtered and washed  
 Ultrasonic lysis of filter captured organism to release deoxyribo nucleic acid (DNA) 
 DNA molecules are mixed with dry PCR reagent 
 Semi nested real time amplification and detection in integrated  reaction tube 
 Print test result and interpretation of the  result 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annex 7: Rapid HIV tests procedures 
KHB     
1. Wear gloves  
2. Remove a test cassette from protective foil pouch,  and place it on flat surface 
3. Label the test device with participant identification number. 
4. Collect 40 µl of blood specimen using a capillary tube by finger stick. 
5. Apply the specimen to the sample well on the device. 
6. Add 1 drop of buffer to the specimen.  
7. Read within 30 minutes. 
STAT-PAK 
1. Wear gloves. 
2. Remove a test cassette from protective foil pouch, and place it on flat surface. 
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3. Label device with participant identification number. 
4. Collect 5 µl of specimen using a new disposable loop.  
5. Dispense the sample in the center of sample well.  
6. Add 3 drops of buffer, holding vial vertically over sample well. 
7. Wait for 10 minutes and read the result.   
UNI-GOLD 
1. Wear gloves. 
2. Remove a test cassette from protective foil pouch, and place it on flat surface. 
3. Label device with participant identification 
4. Collect specimen using the disposable pipette.  
5. Add 2 drops of specimen to the sample port in the device. 
6. Add 2 drops of the appropriate wash reagent to sample port.    
7. Wait for 10 minutes before reading the result.   
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